HOME >> MEDICINE >> NEWS
Harvard Med. School report warns of world health threat

New York---October 28, 1999-- Deadly strains of drug resistant tuberculosis are spreading rapidly and threaten to spiral out of control, according to "The Global Impact of Drug Resistant Tuberculosis", a report released today by Harvard Medical School's Program on Infectious Disease and Social Change and the Open Society Institute. The World Health Organization first sounded the TB alarm six years ago--labeling the airborne bacteria a "global emergency." But with the increasing prevalence of drug resistant strains of the disease, the epidemic has taken a chilling new direction.

In Russia, Estonia and other hotspots around the world cases of multidrug-resistant tuberculosis (MDR-TB) are reaching unprecedented levels. While TB and MDR-TB have traditionally been viewed as a scourge of the poor, the report traces the spread of MDR-TB to Western Europe and North America. The study, commissioned by philanthropist George Soros's Open Society Institute, documents drug-resistant TB in more than 100 countries.

"The rapid rise of multidrug-resistant tuberculosis is a public-health catastrophe of the first order," says the report's lead author Dr. Paul Farmer, an associate professor of social medicine at Harvard Medical School. "MDR-TB is a man-made problem. When patients stop taking or don't take enough of the right medications, they develop resistance to the drugs, and then spread new drug-resistant strains of the bacteria."

Immediate action and a massive infusion of new resources are urgently needed to bring this problem under control. While the report outlines an effective approach to the exploding epidemic, it also points out that without at least $1 billion in new funding for TB treatment in the immediate future, MDR-TB will spread to all corners of the earth.

"If new money isn't made available immediately the epidemic may become virtually impossible to contain," said Dr. Farmer. "It is only a matter of time before MDR-TB becomes a serious threat
'"/>

Contact: Michael Vachon
mvachon@sorosny.org
212-548-0668
Open Society Institute
27-Oct-1999


Page: 1 2

Related medicine news :

1. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
2. Three Harvard Medical School endowed chairs named simultaneously in sleep medicine
3. Civil rights campaign issues at Harvard
4. NYU Child Study Center to honor Larry Summers, President of Harvard and Ann Tenenbaum and Tom Lee
5. Harvard chemist wins national award for creating new molecules
6. Harvard Medical School new digital library to feature MD Consult full text medical resources
7. Harvard researcher receives national award
8. UCSF-Harvard Team Reports Encouraging Results In Drug Study Of Mice With Cancer
9. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
10. School-based smoking prevention programs ineffective
11. Mailman School of Public Health researchers develop infectious disease diagnostic tool

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... bolstered by inspiring human interest stories, which come courtesy of leaders in the nursing ... within the industry, from leading advocates and associations—namely Abilene Christian University. , As ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through ... a partner for the Tamika Catchings Legacy Tour that will commemorate the ... in hardwood basketball surfaces in all forms and levels of the game, Connor Sports ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Hutchison China MediTech (Chi-Med) ... the highly lucrative global oncology and immunology markets. ... first-in-class or best-in-class tyrosine kinase inhibitor (TKI) drugs, ... partners. HCM,s profitable Chinese healthcare business continues to ... progress of the mid-to-late-stage pipeline during 2016-17 (including ...
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
Breaking Medicine Technology:
Cached News: